$BLTE stock is down 9% today. Here's what we see in our data.

$BLTE stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $53,514,113 of trading volume.

Here is what we see in our data on $BLTE (you can track the company live on Quiver's $BLTE stock page):

$BLTE Insider Trading Activity

$BLTE insiders have traded $BLTE stock on the open market 115 times in the past 6 months. Of those trades, 0 have been purchases and 115 have been sales.

Here’s a breakdown of recent trading of $BLTE stock by insiders over the last 6 months:

HENDRIK PETER SCHOLL (Chief Medical Officer) has made 0 purchases and 13 sales selling 20,000 shares for an estimated $2,858,164.
NATHAN L. MATA (Chief Scientific Officer) has made 0 purchases and 93 sales selling 15,000 shares for an estimated $2,411,919.
YU-HSIN LIN (Chief Executive Officer) has made 0 purchases and 4 sales selling 9,200 shares for an estimated $1,669,338.
HAO-YUAN CHUANG (Chief Financial Officer) has made 0 purchases and 4 sales selling 6,200 shares for an estimated $1,125,303.
WAN-SHAN CHEN sold 1,100 shares for an estimated $198,473

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$BLTE Hedge Fund Activity

We have seen 53 institutional investors add shares of $BLTE stock to their portfolio, and 40 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PARADIGM BIOCAPITAL ADVISORS LP added 1,114,784 shares (+inf%) to their portfolio in Q1 2026, for an estimated $177,741,160
UBS GROUP AG removed 543,370 shares (-70.7%) from their portfolio in Q2 2026, for an estimated $83,670,829
RA CAPITAL MANAGEMENT, L.P. removed 432,484 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $68,955,248
HOLOCENE ADVISORS, LP added 410,428 shares (+488.2%) to their portfolio in Q1 2026, for an estimated $65,438,640
POINT72 ASSET MANAGEMENT, L.P. removed 284,437 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $45,350,635
PRICE T ROWE ASSOCIATES INC /MD/ added 281,805 shares (+inf%) to their portfolio in Q1 2026, for an estimated $44,930,989
MARSHALL WACE, LLP removed 192,700 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $30,724,088

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive BLTE Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$BLTE Price Targets

Multiple analysts have issued price targets for $BLTE recently. We have seen 4 analysts offer price targets for $BLTE in the last 6 months, with a median target of $208.0.

Here are some recent targets:

Yi Chen from HC Wainwright & Co. set a target price of $200.0 on 06/15/2026
Graig Suvannavejh from Mizuho set a target price of $215.0 on 05/26/2026
Steve Seedhouse from Cantor Fitzgerald set a target price of $266.0 on 03/03/2026
Judah Frommer from Morgan Stanley set a target price of $201.0 on 03/03/2026

You can track data on $BLTE on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.